3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
1
Conditions
Tumor Lysis Syndrome
2
Lymphoma
1
Leukemia
1
Inflammation
1
Hyperuricemia
1
Hematologic Neoplasms
1
Gout
1
Cardiovascular Diseases
1
Arthritis
1
Interventions
rasburicase
3
Urate Oxidase
3
Febuxostat
2
Allopurinol
2
venetoclax
1
obinutuzumab
1
Lenalidomide
1
Bendamustine Hydrochloride
1
AZD0466
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Tumor Lysis Syndrome
×
Febuxostat
×
Clear all
NCT03605212
2021-06-03
FLORET
Menarini Group
Phase 1/2
Terminated
30 enrolled
14 charts
NCT01724528
2014-11-03
FLORENCE
Menarini Group
Phase 3
Completed
346 enrolled
16 charts